AUROBINDO PHARMA
AUROPHARMA.NS
₹ 418.65
1%

Aurobindo Pharma Ltd

Aurobindo Pharma Ltd is a Mid Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Aurobindo Pharma is ₹ 418.65 that is ₹ 3.65 0.88% with respect to the previous day’s close price. The stock price of Aurobindo Pharma was last updated 1 hour ago.

Aurobindo Pharma Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Aurobindo Pharma Live Share Price Analysis

AUROBINDO PHARMA
₹ 418.65
Open ₹ 415.25
High ₹ 421.20
Marketcap 245.30B
Close ₹ 418.65
Low ₹ 410.45
Volume ₹ 1,663,714.00

The stock of Aurobindo Pharma Ltd strated the trade at an Open price of ₹ 415.25 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 421.20 and an Intraday Low price of ₹ 410.45%. As per last updated 1 hour ago, the Shares of Aurobindo Pharma were trading at a price of ₹ 418.65 which is ₹ 3.65 0.88% as compared the price ₹ 415.00 at which the stock close on the previous trading day. The total traded volume for the day stood at 1,663,714 number of shares.

Candlestick Chart of Aurobindo Pharma Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Aurobindo Pharma Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 418.65₹ 397.20₹ 727.95

Here is Aurobindo Pharma’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 727.95. On the lower side, the stock has been to the 52 weeks low price level of ₹ 397.20. It’s last traded price was ₹ 418.65 as on last update 1 hour ago. The one-year line chart clearly shows how the price of Aurobindo Pharma’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ 36.03 per share (EPS TTM) in the trailing twelve months period. Aurobindo Pharma’s last annual dividend rate was 6%, which translates to a 1.4457831% of annual dividend yield.

Line Chart of Aurobindo Pharma Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Aurobindo Pharma

Aurobindo Pharma Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Aurobindo Pharma are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Aurobindo Pharma

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
ALEMBICLTD.NSALEMBIC LTD
₹ 66.55
NSE
₹ 0.3
0.45%

About Aurobindo Pharma

Aurobindo Pharma Ltd is a Aurobindo Group Company. The company operates in the Pharmaceuticals & Drugs sector. It is a pharmaceutical company. Incorporated in 1986, it has around 35 years of operations. Aurobindo Pharma live share price is ₹ 418.65. It is a Mid Cap stock and had a market capitalization of ₹ 245,303,361,536.00 as on 1 hour ago.

  • Aurobindo Pharma is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).
  • Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics.
  • It is engaged in developing a range of oncology and hormonal products.
  • It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI).
  • It markets its products through chain stores in the United States.
  • It has developed over three injectable penem products.
  • The Company, through its subsidiary, manufactures and sells nutritional supplements.
  • It has over 10 manufacturing units and approximately two research and development centers.
  • The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.

The registered office of Aurobindo Pharma is located in Hyderabad, Telangana. The registrar and share transfer agent for Aurobindo Pharma is K FIN Technologies Pvt Ltd. The Stock Exchanges on which shares of Aurobindo Pharma Ltd is listed includes BSE, NSE, MCX.

AUROBINDO PHARMA
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Employees: 15431
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
AddressGalaxy, Plot No. 1, Hyderabad, India
CountryIndia
Phone91 40 6672 5000
Websitehttps://www.aurobindo.com

Aurobindo Pharma Recent News

No Recent News found for Aurobindo Pharma Ltd.